two friends smiling in a nature setting

340B strategy collection

340B supports access to care across a wide range of covered entities, care models, and pharmacy partnerships. It also creates important considerations for organizations that support, partner with, or invest in 340B-enabled models. Protecting and strengthening that value takes coordinated strategy across pharmacy, finance, and clinical operations, with clear visibility into eligibility risk and changing program requirements. In this collection, we examine how organizations are building sustainable strategies to protect 340B value, strengthen program resilience, and sustain access for the communities they serve.

Contact our team
pharmacist looking at medicine
pharmacist looking at medicine
Fact sheet

Medicaid cuts and 340B: What health systems need to know now

Medicaid cuts under H.R. 1 threaten DSH days and 340B eligibility. We discuss the implications and steps health systems can take now to protect their margin and mission. 

African american woman pharmacist talking to a senior customer in a pharmacy
Chartis top reads

Federal policymaking is reshaping the 340B environment as health systems prepare for 2027

As multiple new 340B policies could coincide in 2027, providers face impacts to their eligibility, reimbursement levels, cash flow, and administrative burdens. We discuss implications and next steps.

Maximize 340B program value 

Chartis looks for opportunity across system pharmacy offices, ambulatory operations, 340B programs, and the revenue cycle to contain costs and grow revenue.

Explore pharmacy enterprise strategy

Related insights

Contact Us

Get in Touch

Let us know how we can help you advance healthcare.

Contact Our Team
About Us

About Chartis

We help clients navigate the future of care delivery.

About Us